Founded in 2005, Korea Institute for Pharmaceutical Policy Affairs, KIPPA, is a non-profit, public foundation, approved by the Korean Ministry of Health and Welfare. The institute is contributed by three relevant parties, the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA), and the Korea Pharmaceutical Distribution Association (KPDA).

KIPPA is a leading research center, which aims to promote public health through the development of policy regarding the rational use of medicines, pharmacy education, pharmacy practice, pharmaceutical industry, and pharmaceutical supply and distribution. In particular, we begin to develop ¡®a community pharmacy model as a health promotion center for community members¡¯. We are collecting and analysing big data accordingly to develop pharmacy-based policies, which pursue maximised pharmacy practice for all the Koreans.

In consequence, KIPPA will consistently implement research tailored to the promotion of health in the nation and worldwide. We kindly ask for supports from our fellow pharmacists, public and associations.

If you have any further enquiries about the institute or research in English, please contact us via e-mail (kippa.org@gmail.com).

Thank you.

Office Address
3FL, 194, Hyoryeong-ro, Seocho-gu, Seoul, Repbulic of Korea

ÇöÀçÀ§Ä¡ : Home : ¾Ë¸²¸¶´ç : ¿¬±¸¼Ò ´º½º
   
¾Ë¸²¸¶´ç
°øÁö»çÇ×
º¸µµÀÚ·á
ÀÎÀçä¿ë
 
 
Á¦   ¸ñ [µ¥Àϸ®ÆÊ]¾à±¹ Á÷¿ø ¾÷¹«¹üÀ§ ÇØ¿Üµµ '±Ø°ú ±Ø'¡¦±¹³»´Â ¾î¶»°Ô?
³»   ¿ë

¾à±¹ Á÷¿ø ¾÷¹«¹üÀ§ ÇØ¿Üµµ '±Ø°ú ±Ø'¡¦±¹³»´Â ¾î¶»°Ô?

                  

±èÁ¤ÁÖ ±âÀÚ 2020-04-08 12:17:46
                       


º¹ÁöºÎ '¾à±¹ ¹× ÀÇ·á±â°ü ¾àÁ¦¾÷¹« °ü¸®Áöħ °³¹ß' ¿¬±¸°á°ú

À§ÇØ¡¤Á¶Á¦ ¾àÁ¦ Àç°í°ü¸®, ¼ö°Å¡¤È¸¼ö¡¤Æó±â µîÀÌ ÁÖ¿ä 'Æ÷ÀÎÆ®'

[µ¥Àϸ®ÆÊ=±èÁ¤ÁÖ ±âÀÚ] ¾à±¹ ºñ¾à»ç Á¾»çÀÚÀÇ ¾÷¹« Çã¿ë±âÁØÀÌ ¼±Áø±¹ÀÌ¶óµµ ±Ø°ú ±ØÀÌ´Ù. Á¢±Ù¼º°ú ÀÚ±¹ »çÁ¤¿¡ µû¸¥ °ÍÀε¥, ¿ªÇÒÀ» Á¦ÇÑÇϰųª È®ÀåÇÏ´õ¶óµµ Á¦ÇѰú ¿¹¿ÜÀÇ ±âÁØÀÌ ¸íÈ®Çϴٴ Ư¡Àº °øÅëÀûÀ̾ ¿ì¸®³ª¶óµµ Âü°íÇÑ ¿¬±¸ °á°ú°¡ ³ª¿Ô´Ù.

ÀǾàǰ Àç°í°ü¸®ÀÇ °æ¿ì ¼ö°Å¿Í ȸ¼ö, Æó±â µîÀÌ ÇÙ½ÉÀ¸·Î, À̸¦ ±âÁØÇÑ ±¹³» Àû¿ëÀÌ Á¦¾ÈµÆ´Ù.

º¸°Çº¹ÁöºÎ°¡ ÀÇ·ÚÇϰí ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò(¼ÒÀå ¹ÚÇý°æ)¿Í Çѱ¹º´¿ø¾à»çȸ(ȸÀå ÀÌÀº¼÷)°¡ ¿¬±¸ ¼öÇàÇÑ '¾à±¹ ¹× ÀÇ·á±â°ü ¾àÁ¦¾÷¹« °ü¸®Áöħ °³¹ß' ÃÖÁ¾º¸°í¼­¿¡´Â ÀÌ °°Àº ¾à±¹ Àη°ú ÀǾàǰ Àç°í°ü¸®¿¡ ´ëÇÑ ¿ì¸®³ª¶ó ÇöȲ°ú ÇØ¿Ü »ç·Ê, Á¦¾È µîÀÌ ´ã°Ü ÀÖ´Ù.

¡ßºñ¾à»ç Àη = ¾à»ç¸¦ Á¦¿ÜÇÑ ¾à±¹ Á¾»çÀÚ ¾÷¹«±âÁØÀº ¿ì¸®³ª¶ó¸¦ Æ÷ÇÔÇØ ¼±Áø±¹µµ ÀÚ±¹ »çÁ¤¿¡ ¸ÂÃç Á¦°¢°¢ÀÌ´Ù.

¿ì¸®³ª¶óÀÇ °æ¿ì 2015³â ¸¸µé¾îÁø KGPP(°¡À̵å¶óÀÎ)ÀÌ ´ëÇ¥ÀûÀε¥, ¾à±¹ °³¼³ÀÚ°¡ Á¾¾÷¿øÀ» µÎ´Â °æ¿ì ÇØ´ç Á¾¾÷¿øÀÌ ¸ÃÀº ¾÷¹«¸¦ ÀûÀýÈ÷ ¼öÇàÇÒ ¼ö ÀÖµµ·Ï ÇÊ¿äÇÑ ±³À°À» Çϸç, ¾à±¹ÀåÀ̳ª °ü¸®¾à»ç´Â Á¾¾÷¿øÀÌ ¼öÇàÇÒ ¾÷¹«¸¦ ¹®¼­·Î ÀÛ¼ºÇϰí ÇØ´ç ¾÷¹« ÀÌÇàÀ» º¸ÀåÇØ¾ß ÇÑ´Ù´Â ÁöħÀÌ ´ã°Ü ÀÖ´Ù.

¶Ç Á¾¾÷¿øÀº ¾à»çÀÇ Á÷Á¢ÀûÀÌ°í ´ë¸éÀûÀÎ °¨µ¶ ÇÏ¿¡¼­¸¸ ¾÷¹«¸¦ ¼öÇàÇØ¾ß ÇÑ´Ù´Â Á¡µµ ¸í½ÃµÅ ÀÖ´Ù.

¿ì¸®¿Í »çÁ¤ÀÌ À¯»çÇÑ ÀϺ»ÀÇ °æ¿ìµµ ÃÖÁ¾ Ã¥ÀÓÀÚ´Â ¾à»çÀ̱⠶§¹®¿¡ ¾à»ç Áö½Ã¿¡ ±âÃÊÇØ º¸Á¶ÀηÂÀº ÆÇ´Ü¿©Áö°¡ ¾ø´Â ±â°èÀû ÀÛ¾÷À̳ª ³³Ç° ¾àÁ¦¸¦ Á¶Á¦½Ç ³» ¼±¹Ý¿¡ Á¤¸®Çϰųª, Á¶Á¦ ÈÄ ¾àÁ¦¸¦ Ä«µå¿¡ ³Ö´Â ÇàÀ§ µîÀ¸·Î Á¦ÇÑÇÑ´Ù.

ƯÈ÷ ÀϺ»Àº ¾à»ç°¡ °Ë¼ö¸¦ Çß´Ù°í ÇÏ´õ¶óµµ ºñ¾à»ç ÀηÂÀº ÀÚ°¡ ¿¬°íÁ¦³ª ¾×Á¦, °¡·ç¾à µî ÀǾàǰÀ» Á÷Á¢ °è·®Çϰųª È¥ÇÕÇÏ´Â °Ô ±ÝÁö´Ù.

¹Ý¸é ¾à±¹ Á¢±Ù¼ºÀÌ ºñ±³Àû ¶³¾îÁö´Â ¹Ì±¹Àº '¾à¹«º¸Á¶¿ø(Å×Å©´Ï¼Ç)Á¦µµ'¸¦ µÎ°í À̵éÀÌ ÇÒ ¼ö ÀÖ´Â ¾÷¹«¿Í ±×·¸Áö ¾ÊÀº ¾÷¹«¸¦ ±¸ºÐÇϰí ÀÖ´Ù. Áï, ¾à»ç¿Í Å×Å©´Ï¼Ç°ú ¾à±¹Á÷¿øÀ¸·Î ±¸ºÐÇØ À̵éÀÇ ¾÷¹«¸¦ ¼¼ºÎÀûÀ¸·Î ±ÔÁ¤Çϰí ÀÖ´Â °ÍÀÌ´Ù.

 ¡ã ¾à±¹ ºñ¾à»ç Àη¿¡ ´ëÇÑ 2015³â KGPP °¡À̵å¶óÀÎ.

À̸¦ Åä´ë·Î ¿¬±¸ÁøÀº ±¹³» Àû¿ë¹æ¾ÈÀ» Á¦½ÃÇß´Ù.

Àû¿ë¹æ¾È¿¡´Â ¾à±¹ û°áÀ¯Áö¿Í ¼ö³³, °¡°ÝÇ¥ ´Þ±â, Àü¹®ÀûÀÌÁö ¾ÊÀº ÀüÈ­ÀÀ´ë, ÀǾàǰ Àç°í°ü¸®³ª ÇàÁ¤¾÷¹« µîÀ» À§ÇØ ÇÊ¿äÇÑ Á¾¾÷¿øÀ» µÑ ¼ö ÀÖ´Â ±âº» ÀüÁ¦°¡ ÀÖ´Ù.

ƯÈ÷ ¿¬±¸ÁøÀº ÀϺ» ±ÔÁ¤Ã³·³ ¾à»ç °¨µ¶ ÇÏ¿¡ Á¾¾÷¿øÀº ÆÇ´ÜÀ» °¡ÇÒ ¿©Áö°¡ ¾ø´Â ±â°èÀûÀÎ ÀÛ¾÷, ³³Ç°µÈ ÀǾàǰÀ» Á¶Á¦½Ç ³» ¼±¹Ý¿¡ Á¤¸®ÇÏ´Â ÇàÀ§ µîÀ» ÇÒ ¼ö ÀÖ´Ù´Â Á¡µµ Á¦½ÃÇß´Ù.

¡ßÀǾàǰ Àç°í°ü¸® = ¾à±¹¿¡¼­ ƯÈ÷ À¯ÀÇÇØ¼­ °ü¸®ÇÏ´Â ¾àÁ¦´Â À§ÇØÀǾàǰ°ú Á¶Á¦¿ë ¾àÁ¦´Ù. KGPP Áöħ¿¡ µû¸£¸é ¾à±¹¿¡¼­ ´Ù·ç´Â ¾àÁ¦´Â ÀǾàǰº° Àç°í ¼ö·®°ú À¯È¿±âÇÑÀ» È®ÀÎÇϰí, À¯È¿±âÇÑÀÌ ÀÓ¹ÚÇϰųª ºÒÇÊ¿äÇÑ ÀǾàǰÀ» ¹Ýȯ, ±³È¯¡¤Æó±âÇØ¾ß ÇÑ´Ù.

ÀÌ Áß ¾à±¹¿¡¼­ À§Çؾà°ú Á¶Á¦¿ë ¾àÁ¦ Àç°í´Â ƯÈ÷ Áß¿äÇÑ ¹®Á¦´Ù. ¼±Áø±¹ Áß ÀϺ»ÀÇ °æ¿ì ºÒ·®¾à ó¸®ÀåºÎ ±âÀ縦 ¹ý¿¡ ¸í½ÃÇϰí ÀÖÀ¸¸ç ¾ÆÀÏ·£µåÀÇ °æ¿ì ÁöħÀ» ¸¸µé¾î À§Á¶¡¤ºÒ·®¾à ÁÖ¹®°ú ¸ñ°Ý½Ã º¸°í, ¹ß°ß ½Ã ºÐ¸® µî¿¡ ´ëÇÑ °¡À̵带 Çϰí ÀÖ´Ù.

À̸¦ Åä´ë·Î ¿¬±¸ÁøÀº ÀǾàǰ µîÀÌ ¾ÈÀü¼º¡¤À¯È¿¼º¿¡ ¹®Á¦°¡ ÀÖ´Ù´Â »ç½ÇÀ» ¾Ë°Ô µÇ¸é Áöü ¾øÀÌ À¯Åë ÁßÀÎ ÀǾàǰ µîÀ» ȸ¼öÇϰųª ȸ¼ö¿¡ ÇÊ¿äÇÑ Á¶Ä¡¸¦ ÇÏ´Â ³»¿ëÀ» °ñÀÚ·Î ±¹³» Àû¿ë¹æ¾ÈÀ» Á¦½ÃÇß´Ù.

¹Ýǰ¡¤Æó±âÀÇ °æ¿ì FIP-WHO GPP¿¡µµ °¡À̵å¶óÀÎÀÌ Á¦½ÃµÅ ÀÖ´Ù. ÀÌ¿¡ µû¸£¸é ¿À·¡µÈ Á¦Ç°À» ¾ø¾Ö´Â °úÁ¤¿¡´Â ÀǾàǰ »ùÇõµ Ç×»ó Æ÷ÇÔÇϰí, ȸ¼öµÈ ¾àÁ¦°¡ ÇâÈÄ Á¶Á¦³ª ¹èÆ÷·Î ´Ù½Ã »ç¿ëµÇ´Â °ÍÀ» ¸·±â À§ÇØ È¸¼öÁï½Ã µû·Î º¸°üÇØ¼­ Æó±âÇØ¾ß ÇÑ´Ù.

¶ÇÇÑ È¯ÀÚ¿Í ÀϹÝÀο¡°Ô À¯È¿±âÇÑÀÌ ¸¸·áµÇ°Å³ª ºÒÇÊ¿äÇÑ ÀǾàǰ, ÀÇ·á±â±¸ ȸ¼ö¸¦ µ¶·ÁÇÏ°í ÆóÀǾàǰÀ» ¾ÈÀüÇÏ°Ô ¼ö°ÅÇÒ ¹æ¹ýÀ» ¸¶·ÃÇϵÇ, ºÒ°¡ÇÑ °æ¿ì ¾ÈÀüÆó±â ¹æ¹ý¿¡ ´ëÇØ ÀûÀýÇÑ Á¤º¸¸¦ Á¦°øÇϵµ·Ï Çϰí ÀÖ´Ù.

À̸¦ Åä´ë·Î ¿¬±¸ÁøÀº ±¹³» Àû¿ë¹æ¾ÈÀ» Á¦½ÃÇß´Ù. ¸ÕÀú ¾à»ç´Â °¡Á¤ ³» ÆóÀǾàǰ(À¯È¿±âÇÑÀÌ ¸¸·áµÇ°Å³ª ºÒÇÊ¿äÇÑ ÀǾàǰ)ÀÌ ¾ÈÀüÇÏ°Ô ¼ö°ÅµÇµµ·Ï ³ë·ÂÇϸç Á¤ºÎ¿Í Áö¹æÀÚÄ¡´Üü¿Í Çù·ÂÀ» ±Ç°íÇß´Ù.

¿©±â¿¡´Â ȯÀڷκÎÅÍ ¼ö°ÅµÈ ÀǾàǰ, À¯È¿±âÇÑÀÌ °æ°úµÈ ÀǾàǰ, À§ÇØÀǾàǰ µîÀÇ Æó±â´ë»ó ÀǾàǰÀº ´Ù¸¥ ¾àÁ¦¿Í ºÐ¸® º¸°üÇØ¼­ ÀϹÝÀÎÀÌ Á¢±ÙÇÒ ¼ö ¾øµµ·Ï ÇÏ´Â ³»¿ëµµ Æ÷ÇԵŠÀÖ´Ù.
±èÁ¤ÁÖ ±âÀÚ (jj0831@dailypharm.com



 

¹øÈ£ ÷ºÎ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Á¶È¸
9 [µ¥Àϸ®ÆÊ]¾à±¹ Á÷¿ø ¾÷¹«¹üÀ§ ÇØ¿Üµµ '±Ø°ú ±Ø'¡¦±¹³»´Â ¾î¶»°Ô? ±è¼±Èñ 2020-04-09 1099
8 [¾à»ç°ø·Ð]ÀǾàǰÁ¤Ã¥¿¬, Áö¿ª¾à±¹ ¸ðµ¨ ¿Ï¼º ³ë·Â¡¦Á¤±âÀÌ»çȸ °³ÃÖ ±è¼±Èñ 2020-04-09 705
7 [µ¥Àϸ®ÆÊ]ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò, ¿Â¶óÀÎ ÀÌ»çȸ ¿­°í »ç¾÷ È®Á¤ ±è¼±Èñ 2020-04-09 723
6 [´ëÇѾà»çÀú³Î]»ç·Ê °íÂûÀ» ÅëÇÑ ¹Ù¶÷Á÷ÇÑ ¾à»ç¿¬¼ö±³À°ÀÇ ¹æÇâ 4 ±è¼±Èñ 2020-04-09 690
5 [´ëÇѾà»çÀú³Î]»ç·Ê °íÂûÀ» ÅëÇÑ ¹Ù¶÷Á÷ÇÑ ¾à»ç¿¬¼ö±³À°ÀÇ ¹æÇâ 3 ±è¼±Èñ 2020-04-09 596
4 [´ëÇѾà»çÀú³Î]»ç·Ê °íÂûÀ» ÅëÇÑ ¹Ù¶÷Á÷ÇÑ ¾à»ç¿¬¼ö±³À°ÀÇ ¹æÇâ 2 ±è¼±Èñ 2020-03-24 712
3 [ÄíŰ´º½º]WHO, Àü¼¼°è ¸¶½ºÅ© »ý»ê·® 40% Áõ°¡ ÇÊ¿ä ±è¼±Èñ 2020-03-16 1189
2 [´ëÇѾà»çÀú³Î]¹Ì±¹, ½Ã´ë ¸ÂÃç ±³À°°ú¸ñ º¯È­¡¦»çÈÄÆò°¡µµ Àǹ«È­ ±è¼±Èñ 2020-03-16 889
1 [´ëÇѾà»çÀú³Î]ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¸®Æ÷Æ®: Ä¿¹Â´ÏƼÄɾî, ¼¼°èÀÇ ´äÀº ¡®¾à»ç¡¯¿´´Ù ±è¼±Èñ 2020-03-10 948

ÀÌÀü 10ÆäÀÌÁö [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8]  [9]  ´ÙÀ½ 10ÆäÀÌÁö

 
 

¼­¿ï ¼­Ãʱ¸ È¿·É·Î194, 3Ãþ (Àç)ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò TEL : 02) 3474-5301 / FAX : 02)3474-5306

COPYRIGHT (C) 2006 KOREA INSTITUTE FOR PHARMACEUTICAL POLICY AFFAIRS ALL RIGHTS RESERVED. FOR MORE INFORMATION MAL kippa.org@gmail.com

±âºÎ±Ý ¾È³»